News

GJE client Lundbeckfonden Emerge invests €2.6 million in SNIPR Biome Limited

On August 25 2017, Lundbeckfonden Emerge announced the completion of a €2.6 million investment in SNIPR Biome Limited. SNIPR Biome is pioneering its proprietary CRISPR technology to revolutionise the treatment of microbial diseases. The constructs developed by SNIPR can subvert elements of the endogenous bacterial CRISPR machinery to targetedly eliminate...

Read more

Teva Pharmaceutical Industries’ European Patent EP 2361924 revoked

On 12th September 2017, Teva Pharmaceutical Industries’ European Patent EP 2361924 was revoked. The patent was one of a family of patents covering Copaxone® (glatiramer acetate injection), its intermediates and processes for its production. Global Copaxone® franchise sales were $4.1 billion in 2016. The opposition was filed by Mylan, Synthon BV,...

Read more

Rowena Price recognised by Expert Guides

We would like to congratulate Rowena Price for being listed by Expert Guides as a leading Woman in Business Law. Expert Guides has been researching the world’s legal market for over 20 years and has become one of the most trusted resources for international buyers of legal services. The guide endorses the...

Read more

GJE recognised by Managing IP Stars 2017

We are delighted to be recognised in the 2017 edition of Managing IP Stars. The publication recognises the world’s leading IP firms and practitioners through rigorous and independent research. We would like to congratulate our partners Peter Finnie, Lucy Samuels, Peter Arrowsmith, Arnie Clarke and Michael Lord for receiving high...

Read more

Paediatric extensions now available in Norway

SPCs filed in Norway that have an expiry date later than 1 March 2017 can now be extended by a further six months, provided that the conditions of Regulation (EC) No 1901/2006 and transitional regulations are met.  Applications for paediatric extensions can be submitted from 1 August 2017. Of note...

Read more